Depression

Showing NaN - NaN of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Depression, Anxiety, Suicide Trial in Cincinnati (Clairity)

Enrolling by invitation
  • Depression
  • +3 more
  • Clairity
  • Cincinnati, Ohio
    Xavier University Psychological Services Clinic
Aug 22, 2022

Depression, Bipolar I Disorder Trial in Worldwide (Cariprazine, Placebo)

Recruiting
  • Depression
  • Bipolar I Disorder
  • Bentonville, Arkansas
  • +51 more
Aug 22, 2022

Depression Trial in United States (Esketamine, Cognitive Behavioral Therapy (CBT), Antidepressant)

Not yet recruiting
  • Depression
  • New Haven, Connecticut
  • +5 more
Aug 17, 2022

Depression, Anxiety, Bipolar Disorder Trial in Stanford, Cincinnati (Escitalopram, Cognitive behavioral Psychotherapy)

Active, not recruiting
  • Depression
  • +2 more
  • Stanford, California
  • +1 more
Feb 25, 2022

Anxious Depression, Depression Trial in Cincinnati (Escitalopram, Duloxetine)

Recruiting
  • Anxious Depression
  • Depression
  • Cincinnati, Ohio
    University of Cincinnati, Department of Psychiatry & Behavioral
Feb 14, 2022

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

PTSD, Depression, Alcohol-Related Disorders Trial in United States (Motivational Interviewing, Cognitive Behavioral Therapy

Completed
  • Posttraumatic Stress Disorder
  • +10 more
  • Motivational Interviewing
  • +13 more
  • Scottsdale, Arizona
  • +23 more
Jul 1, 2021

Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar Disorder
  • Depression
  • Birmingham, Alabama
  • +88 more
Feb 19, 2019

Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar Disorder
  • Depression
  • Little Rock, Arkansas
  • +73 more
Jan 10, 2019

Depression Trial in Worldwide (Armodafinil)

Terminated
  • Depression
  • Birmingham, Alabama
  • +157 more
Aug 23, 2018

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712, Escitalopram, Fluoxetine)

Completed
  • Depressive Disorder
  • +4 more
  • Birmingham, Alabama
  • +143 more
Sep 14, 2018

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (Placebo + ADT, Brexpiprazole +ADT)

Completed
  • Depressive Disorder
  • +4 more
  • Placebo + ADT
  • Brexpiprazole +ADT
  • Birmingham, Alabama
  • +46 more
Aug 17, 2018

Depression Trial in Cincinnati (N-acetyl cysteine)

Unknown status
  • Depression
  • N-acetyl cysteine
  • Cincinnati, Ohio
    University of Cincinnati, Department of Psychiatry & Behavioral
May 7, 2018

Binge Eating, Depression Trial in Cincinnati (Duloxetine, Placebo)

Completed
  • Binge Eating
  • Depression
  • Cincinnati, Ohio
    University of Cincinnati and Lindner Center of HOPE
Jul 20, 2017

Depression Trial in United States (6(S)-5-MTHF(Deplin), Placebo)

Completed
  • Depression
  • 6(S)-5-MTHF(Deplin)
  • Placebo
  • San Diego, California
  • +5 more
Mar 28, 2017

Sexual Dysfunctions, Psychological, Depression Trial in United States (flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs,

Terminated
  • Sexual Dysfunctions, Psychological
  • Depression
  • flibanserin 50 mg to 100 mg qhs
  • +2 more
  • Costa Mesa, California
  • +41 more
Jul 14, 2016

Depression, Suicidal Ideation, Suicidal Impulses Trial in Cincinnati (Intranasal Ketamine, Intranasal Saline Placebo)

Unknown status
  • Depression
  • +2 more
  • Intranasal Ketamine
  • Intranasal Saline Placebo
  • Cincinnati, Ohio
    University of Cincinnati
Aug 3, 2016

Depression Trial in Worldwide (Armodafinil, Placebo)

Completed
  • Depression
  • Birmingham, Alabama
  • +129 more
Apr 26, 2016

Mapping Mood in Subthalamic Nucleus in Parkinson's Disease (PD)

Completed
  • Parkinson's Disease
  • +2 more
    • St. Louis, Missouri
    • +1 more
    May 3, 2016

    Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)

    Completed
    • Depressive Disorder
    • +4 more
    • OPC-34712 + ADT
    • Placebo + ADT
    • Birmingham, Alabama
    • +70 more
    Nov 30, 2015

    Distress, Anxiety, Depression Trial in United States (Acceptance and Commitment Therapy, Present Centered Therapy)

    Completed
    • Distress
    • +3 more
    • Acceptance and Commitment Therapy
    • Present Centered Therapy
    • La Jolla, California
    • +5 more
    Sep 18, 2015

    Depression Trial in Worldwide (Duloxetine, Escitalopram, BMS-820836 Placebo)

    Completed
    • Depression
    • Birmingham, Alabama
    • +92 more
    Sep 23, 2015

    Depression Trial in Worldwide (Placebo matching with BMS-820836, BMS-820836)

    Terminated
    • Depression
    • Birmingham, Alabama
    • +143 more
    Sep 23, 2015

    Convulsion, Non-Epileptic, Conversion Disorder, Depression Trial in Stanford, Cincinnati, Providence (drug, behavioral, other)

    Completed
    • Convulsion, Non-Epileptic
    • +4 more
    • Stanford, California
    • +2 more
    Nov 7, 2014